Welcome to our dedicated page for Aveanna Healthcare Holdings news (Ticker: AVAH), a resource for investors and traders seeking the latest updates and insights on Aveanna Healthcare Holdings stock.
Aveanna Healthcare Holdings Inc. reports developments for a home-based healthcare platform serving pediatric and adult patient populations across 38 states. Company updates commonly cover nursing, rehabilitation services, school-based occupational nursing, therapy services, day treatment centers, home health and hospice, enteral nutrition products, case management, and respite care for medically fragile and chronically ill patients.
Recurring AVAH news includes earnings releases, financial guidance, investor presentations and conference participation, as well as clinical quality initiatives such as Heartways program certification. Updates also address community-service programs and operating themes tied to care coordination among payers, physicians, hospitals, and other healthcare providers.
Aveanna Healthcare (NASDAQ: AVAH) announced that its management team will participate in the Deutsche Bank 2026 Healthcare Summit in New York on September 16, 2026. Management will host a fireside chat at 1:00 p.m. EST and hold 1x1 investor meetings the same day.
A simultaneous webcast and limited-time replay will be accessible through the Investor Relations section of Aveanna’s website. Aveanna, headquartered in Atlanta, operates in 39 states, providing pediatric and adult home health, hospice, therapy, and related healthcare services.
Aveanna Healthcare (NASDAQ: AVAH) announced that its management team will participate in the 2026 Jefferies Healthcare Services and Technology Conference in Nashville on September 15, 2026. Management will present at 4:10 p.m. CST and hold 1x1 investor meetings, with a simultaneous webcast and limited-time replay available via Aveanna’s investor relations website.
Aveanna Healthcare (NASDAQ: AVAH) announced the pricing of a secondary offering of 15,000,000 shares of common stock by certain selling stockholders at $11.75 per share. The selling stockholders, including affiliates of J.H. Whitney Equity Partners VII and certain current and former directors and officers, will receive all net proceeds.
Affiliates of J.H. Whitney Equity Partners VII granted the underwriter a 30‑day option to buy up to 2,250,000 additional shares. Aveanna is not selling any shares and will not receive proceeds. The offering is expected to settle on August 24, 2026, subject to customary conditions, with RBC Capital Markets acting as sole book‑running manager under an effective Form S‑3 shelf registration.
Aveanna Healthcare (NASDAQ: AVAH) announced that certain selling stockholders, including affiliates of J.H. Whitney Equity Partners VII and certain current and former directors and officers, have launched a secondary offering of 15,000,000 shares of Aveanna common stock.
Certain J.H. Whitney affiliates plan to grant the underwriter a 30-day option to buy up to an additional 2,250,000 shares. The selling stockholders will receive all net proceeds. Aveanna will not issue any shares in this offering and will not receive any proceeds. RBC Capital Markets is acting as sole book-running manager under an effective SEC shelf registration on Form S-3.
Aveanna Healthcare Holdings (NASDAQ: AVAH) reported second quarter 2026 revenue of $670.5 million, up 13.7% year over year. Net income rose to $40.3 million from $27.0 million, with diluted EPS of $0.18 and adjusted diluted EPS of $0.22. Adjusted EBITDA was $95.4 million, an 8.0% increase, representing a 14.2% margin.
For the first six months of 2026, revenue reached $1,318.4 million, up 14.8%, and net income was $81.9 million. Adjusted EBITDA was $179.8 million, up 15.4%. The company reported cash of $97.2 million, total debt of $1,483.4 million, and free cash flow of $75.4 million. Aveanna raised full-year 2026 guidance to revenue of more than $2.68 billion and Adjusted EBITDA of more than $365 million.
Aveanna Healthcare (NASDAQ: AVAH) will release its second quarter 2026 results before the market opens on Thursday, August 13, 2026, followed by a conference call at 10:00 a.m. Eastern Time. Investors can join via phone, webcast on the Investor Relations website, or access replays through August 20, 2026.
Aveanna Healthcare (NASDAQ: AVAH) completed its acquisition of Family First Homecare, a pediatric home care provider with 27 locations across seven states. The $175.5 million cash deal was funded with cash on hand.
Aveanna raised its full-year 2026 guidance to $2.63–$2.65 billion in revenue and $338–$342 million in Adjusted EBITDA, reflecting Family First Homecare’s expected $70 million revenue and $10 million Adjusted EBITDA.
Aveanna Healthcare (Nasdaq: AVAH) announced a successful repricing of its first lien and revolving credit facilities.
The new terms reduce applicable interest rate margins by 50 basis points, with a further 25 basis point reduction available if the borrower attains at least a B2 or B credit rating, supporting balance sheet strength and strategic flexibility.
Aveanna Healthcare (NASDAQ: AVAH) reported Q1 2026 revenue of $647.9 million, up 15.9% year over year, with net income of $41.7 million versus $5.2 million and diluted EPS of $0.19.
Adjusted EBITDA rose 25.2% to $84.4 million, and full-year 2026 revenue and Adjusted EBITDA guidance were both raised.
Aveanna (NASDAQ: AVAH) announced that its management team will participate in the William Blair 46th Annual Growth Stock Conference in Chicago on June 2, 2026. Management will present at 2:40 p.m. CST and host same-day 1x1 investor meetings, with a live webcast and limited-time replay via the company’s investor relations website.